Clinical trial
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
NCT02082886 is registered in ClinicalTrials.gov with Edward-Elmhurst Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry
- Lead sponsor
- Edward-Elmhurst Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- January 31, 2020
- Enrollment
- 193 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.